metronidazole has been researched along with Colitis Gravis in 142 studies
Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The fecal flora obtained from 13 patients with ulcerative colitis was examined at the beginning of a pouchitis episode before treatment, during treatment with metronidazole or ciprofloxacin, and during pouchitis-free periods." | 9.11 | Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. ( Gosselink, MP; Hop, WC; Laman, JD; Ruseler-van Embden, JG; Schouten, WR; van Lieshout, LM, 2004) |
| "Metronidazole is effective for the treatment of acute pouchitis after ileal pouch-anal anastomosis, but it has not been directly compared with other antibiotics." | 9.09 | A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. ( Achkar, JP; Bambrick, ML; Bevins, CL; Brzezinski, A; Fazio, VW; Lashner, BA; Ormsby, AH; Remzi, FH; Seidner, DL; Shen, B, 2001) |
| "In this retrospective cohort study, we demonstrated no significant difference in the real-world effectiveness of ciprofloxacin, metronidazole, or combination therapy for the initial episode of pouchitis." | 8.31 | The Comparative Effectiveness of Ciprofloxacin and Metronidazole for an Initial Episode of Pouchitis: A Propensity-Matched Study. ( Barnes, EL; Desai, A; Kochhar, GS, 2023) |
| "We present the first case of metronidazole-related acute pancreatitis during a relapse of ulcerative colitis." | 7.74 | Acute pancreatitis as a possible consequence of metronidazole during a relapse of ulcerative colitis. ( Ekonomou, IA; Giannoulis, EK; Giannoulis, KE; Savopoulos, CG; Tsesmeli, NE; Vretou, EE, 2007) |
| "Pouch contents of patients with ongoing pouchitis or an episode within the previous year released significantly more hydrogen sulfide than did the contents of patients who never had an attack of pouchitis and those with longstanding inactive disease." | 7.73 | Association between fecal hydrogen sulfide production and pouchitis. ( Furne, JK; Levitt, MD; Madoff, RD; Ohge, H; Rothenberger, DA; Springfield, J, 2005) |
| " When compared to placebo, rifaximin was found to be the best antibiotic for acute pouchitis whereas ciprofloxacin ranked highest against metronidazole." | 5.22 | Network meta-analysis: efficacy of treatment for acute, chronic, and prevention of pouchitis in ulcerative colitis. ( Poo, S; Segal, JP; Sriranganathan, D, 2022) |
| "The fecal flora obtained from 13 patients with ulcerative colitis was examined at the beginning of a pouchitis episode before treatment, during treatment with metronidazole or ciprofloxacin, and during pouchitis-free periods." | 5.11 | Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. ( Gosselink, MP; Hop, WC; Laman, JD; Ruseler-van Embden, JG; Schouten, WR; van Lieshout, LM, 2004) |
| "Metronidazole is effective for the treatment of acute pouchitis after ileal pouch-anal anastomosis, but it has not been directly compared with other antibiotics." | 5.09 | A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. ( Achkar, JP; Bambrick, ML; Bevins, CL; Brzezinski, A; Fazio, VW; Lashner, BA; Ormsby, AH; Remzi, FH; Seidner, DL; Shen, B, 2001) |
| "For acute pouchitis, very low quality evidence suggests that ciprofloxacin may be more effective than metronidazole." | 4.91 | Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. ( Holubar, SD; Pardi, DS; Sandborn, WJ; Singh, S; Stroud, AM, 2015) |
| " For the treatment of acute pouchitis (4 RCTS, 5 agents), ciprofloxacin was more effective at inducing remission than metronidazole." | 4.86 | Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. ( Cima, RR; Holubar, SD; Pardi, DS; Sandborn, WJ, 2010) |
| "In this retrospective cohort study, we demonstrated no significant difference in the real-world effectiveness of ciprofloxacin, metronidazole, or combination therapy for the initial episode of pouchitis." | 4.31 | The Comparative Effectiveness of Ciprofloxacin and Metronidazole for an Initial Episode of Pouchitis: A Propensity-Matched Study. ( Barnes, EL; Desai, A; Kochhar, GS, 2023) |
| "5%) used antibiotics for pouchitis, predominantly ciprofloxacin." | 4.12 | Long-term Antibiotic Treatment in Pouchitis-Patterns of Use and Safety. ( Avraham, Y; Banon, L; Bar, N; Cohen, NA; Dotan, I; Dubinsky, V; Gophna, U; Maharshak, N; Tulchinsky, H; Weiss, GA, 2022) |
| "The concept that the gut microbiota plays a major role in the development of pouchitis in ulcerative colitis patients after restorative proctocolectomy with ileal pouch-anal anastomosis, is widely accepted and supported by a widespread use of some antibiotics (metronidazole and/or ciprofloxacin, rifaximin) to treat this condition." | 3.80 | Role of probiotics in the management of pouchitis. ( Guslandi, M, 2014) |
| "We present the first case of metronidazole-related acute pancreatitis during a relapse of ulcerative colitis." | 3.74 | Acute pancreatitis as a possible consequence of metronidazole during a relapse of ulcerative colitis. ( Ekonomou, IA; Giannoulis, EK; Giannoulis, KE; Savopoulos, CG; Tsesmeli, NE; Vretou, EE, 2007) |
| "Pouch contents of patients with ongoing pouchitis or an episode within the previous year released significantly more hydrogen sulfide than did the contents of patients who never had an attack of pouchitis and those with longstanding inactive disease." | 3.73 | Association between fecal hydrogen sulfide production and pouchitis. ( Furne, JK; Levitt, MD; Madoff, RD; Ohge, H; Rothenberger, DA; Springfield, J, 2005) |
| "The observing of pouchitis at a patient with ulcerative colitis with onset 4 months after the closing of the ileostoma, protecting the reservoir and with good response to metronidazole, was the reason for performing a literature review of the modern problems of this complication." | 3.72 | [Pouchitis, on the basis of a single observation]. ( Aleksandrova, A; Nedin, D, 2004) |
| "To evaluate the potential for pharmacokinetic interactions between MMX mesalamine and amoxicillin, ciprofloxacin extended release (XR), metronidazole, or sulfamethoxazole in four open-label, randomized, placebo-controlled, two-period crossover studies." | 2.79 | Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials. ( Barrett, K; Corcoran, M; Inglis, S; Martin, P; Pierce, D; Preston, P; Thompson, TN; Willsie, SK, 2014) |
| "The incidence of overall surgical site infection was significantly lower in group A (6/97 patients, 6." | 2.78 | Preoperative oral antibiotics and intravenous antimicrobial prophylaxis reduce the incidence of surgical site infections in patients with ulcerative colitis undergoing IPAA. ( Ikeuchi, H; Matsuoka, H; Nakajima, K; Oshima, T; Sasako, M; Takesue, Y; Tomita, N; Uchino, M, 2013) |
| "Fusobacterium varium may contribute to ulcerative colitis (UC)." | 2.75 | Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial. ( Chiba, T; Kato, K; Mabe, K; Mizokami, Y; Murakami, K; Ohkusa, T; Okayasu, I; Sato, N; Sugiyama, T; Tajiri, H; Takeuchi, Y; Terao, S; Watanabe, S; Yamato, S; Yanaka, A; Yokoyama, T, 2010) |
| "Twenty patients with ulcerative colitis were randomly assigned into the antibiotic treatment group (amoxicillin, tetracycline and metronidazole for 2 weeks) and no-antibiotics group." | 2.71 | Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy. ( Benno, Y; Hayashi, H; Hirai, S; Hojo, M; Kobayashi, O; Miwa, H; Nomura, T; Ogihara, T; Ohkusa, T; Okayasu, I; Sakamoto, M; Sato, N; Takei, Y; Terai, T; Yoshida, T, 2005) |
| "Metronidazole has been used to treat pouchitis, but there are no controlled data that show it is effective." | 2.67 | Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. ( Madden, MV; McIntyre, AS; Nicholls, RJ, 1994) |
| "Thirty nine patients with severe ulcerative colitis were randomised on admission to hospital to receive either intravenous metronidazole 500 mg eight hourly (19 patients) or an identical intravenous placebo (20 patients)." | 2.66 | Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. ( Chapman, RW; Jewell, DP; Selby, WS, 1986) |
| "Metronidazole was found to be slightly more effective than sulfasalazine, a difference statistically significant only at 12 months." | 2.66 | A comparison of metronidazole and sulfasalazine in the maintenance of remission in patients with ulcerative colitis. ( Bar Meir, S; Delpre, G; Eshchar, J; Fireman, Z; Gilat, T; Leichtman, G, 1989) |
| " Metronidazole and azathioprin are considered to be reserve drugs and can be used in the treatment of fistulae or in order to cut down the dosage of prednisolone during remission." | 2.66 | [Drug therapy of chronic inflammatory intestinal diseases--current status of 5-aminosalicylic acid]. ( Gerok, W; Schölmerich, J, 1986) |
| "Four studies assessed treatment of acute pouchitis." | 2.61 | Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. ( Holubar, SD; Nguyen, N; Pardi, DS; Singh, S; Zhang, B, 2019) |
| "Patients with pouchitis have a wide range of symptoms, endoscopic and histologic features, disease course, and prognosis." | 2.61 | Prevention and Medical Treatment of Pouchitis In Ulcerative Colitis. ( Benlice, C; Shen, B; Steele, SR, 2019) |
| "Pouchitis is a common and long-term complication of ileal pouch-anal anastomosis in patients with underlying ulcerative colitis." | 2.43 | [Diagnosis and medical treatment of pouchitis in ileal pouch-anal anastomosis in patients with ulcerative colitis]. ( Fujii, T; Kawamata, S; Matsushita, M; Okazaki, K; Shimatani, M, 2005) |
| "One of them also had primary sclerosing cholangitis." | 2.42 | [Pancreatitis accompanying inflammatory bowel diseases, and our observations]. ( Aleksandrova, A; Nedin, D, 2004) |
| "In general, patients with Crohn's disease are not usually offered IPAA, because recurrence of disease, fistulas, abscesses, and strictures may lead to a higher incidence of pouch failure." | 2.41 | Complications after ileal pouch-anal anastomosis. ( Lichtenstein, GR; Stein, RB, 2000) |
| "Treatment of pouchitis is largely empirical and few controlled studies have been carried-out." | 2.41 | Review article: treatment of mild to moderate ulcerative colitis and pouchitis. ( Amadini, C; Campieri, M; Gionchetti, P; Rizzello, F; Venturi, A, 2002) |
| "In both ulcerative colitis and Crohn's disease 5-ASA has proved effective in the acute phase of the disease." | 2.39 | Medical management of patients with difficult-to-treat inflammatory bowel disease. ( van Hogezand, RA, 1994) |
| "Rectovaginal fistulas secondary to ulcerative colitis may be treated by ileoanal pouch anastomosis and primary repair." | 2.38 | Perianal inflammatory conditions in inflammatory bowel disease. ( Gordon, PH; Stein, BL, 1993) |
| "Basis treatment of severe ulcerative colitis and Crohn's disease comprises the systemic administration of corticosteroids." | 2.38 | [Conservative therapy of ulcerative colitis and Crohn disease]. ( Kreisel, W; Rasenack, J, 1991) |
| "The elective treatment for acute pouchitis is antibiotics." | 1.56 | Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment. ( Barreiro-de Acosta, M; Beltrán, B; Chaparro, M; Espín, E; Ferrer Bradley, I; Gisbert, JP; Guarner, F; Gutiérrez, A; Marín-Jimenez, I; Nos, P; Rodríguez-Lago, I, 2020) |
| "We identified 461 cases of ulcerative colitis (UC) and 683 cases of Crohn's disease (CD)." | 1.56 | Antibiotic Use in Childhood and Adolescence and Risk of Inflammatory Bowel Disease: A Case-Control Study in the UK Clinical Practice Research Datalink. ( Jick, S; Troelsen, FS, 2020) |
| "Four studies assessed treatment of acute pouchitis." | 1.51 | Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. ( Holubar, SD; Nguyen, N; Pardi, DS; Singh, S; Zhang, B, 2019) |
| "A case of amoebic colitis and liver abscess is described in a previously fit 59-year old man who had been given the incorrect diagnosis of ulcerative colitis." | 1.46 | Learning points from a case of severe amoebic colitis. ( Al-Badri, A; Dryden, M; Dua, A; Petridou, C; Saeed, K, 2017) |
| "Reversible posterior leukoencephalopathy syndrome (RPLS) is a clinical syndrome of varying etiologies with similar neuroimaging findings." | 1.43 | Reversible Posterior Leukoencephalopathy Syndrome Associated with Treatment for Acute Exacerbation of Ulcerative Colitis. ( Ashida, T; Kikuchi, S; Maemoto, A; Orii, F, 2016) |
| "Pouchitis was classified as acute or chronic pouchitis." | 1.39 | Clinical features and management of pouchitis in Japanese ulcerative colitis patients. ( Bando, T; Ikeuchi, H; Matsuoka, H; Takesue, Y; Tomita, N; Uchino, M, 2013) |
| "Pouchitis is the most common long-term complication after restorative total proctocolectomy and IPAA for ulcerative colitis." | 1.38 | The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis. ( Funayama, Y; Haneda, S; Ogawa, H; Sasaki, I; Shibata, C; Suzuki, H; Takahashi, K; Watanabe, K, 2012) |
| "hominis in refractory ulcerative colitis." | 1.37 | Six ulcerative colitis patients with refractory symptoms co-infective with Blastocystis hominis in China. ( Hu, PJ; Lin, XC; Tai, WP; Wu, J, 2011) |
| "We describe a pediatric case of Sweet syndrome presenting 10 days after treatment with azathioprine." | 1.37 | Azathioprine hypersensitivity presenting as sweet syndrome in a child with ulcerative colitis. ( Choe, YH; Jang, KT; Kim, MJ, 2011) |
| "However, the exact role of bacteria in ulcerative colitis (UC) has still to be elucidated." | 1.35 | Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis. ( Benno, Y; Kudo, T; Nishikawa, J; Sakata, S; Sugiyama, T, 2009) |
| "The incidence of PPI in patients with ulcerative colitis/indeterminate colitis is 5." | 1.35 | Incidence and short-term implications of prepouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. ( Bell, AJ; Ciclitira, PJ; Clark, SK; McLaughlin, SD; Nicholls, RJ; Tekkis, PP, 2009) |
| "Treatment with metronidazole suppositories improved his symptoms and avoided further inappropriate intervention." | 1.33 | "Diversion" colitis caused by Clostridium difficile infection: report of a case. ( Feakins, RM; Irving, PM; Rampton, DS; Tsironi, E, 2006) |
| "The medical treatment of acute pouchitis was usually oral metronidazole (250 mg twice daily) for 2 weeks or oral ciprofloxacin (200 mg thrice daily) in patients who could not tolerate metronidazole." | 1.32 | Incidence and therapeutic outcome of pouchitis for ulcerative colitis in Japanese patients. ( Ikeuchi, H; Nakamura, M; Nakano, H; Noda, M; Uchino, M; Yamamura, T; Yanagi, H, 2004) |
| "A further 2 patients (4%) had treatment resistant pouchitis and required pouch excision." | 1.31 | Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome. ( Bartolo, DC; Madiba, TE, 2001) |
| "Episodic pouchitis is easily treated and causes minimum functional consequences, whereas chronic pouchitis increases defecation frequency and needs prolonged medication." | 1.30 | Functional results after restorative proctocolectomy complicated by pouchitis. ( Järvinen, H; Keränen, U; Luukkonen, P, 1997) |
| "Records of 217 patients with mucosal ulcerative colitis who underwent restorative proctocolectomy with a stapled ileal pouch-anal anastomosis without anal mucosectomy from 1987 through 1990 were retrospectively reviewed." | 1.29 | Anal canal inflammation after ileal pouch-anal anastomosis. The need for treatment. ( Fazio, VW; Lavery, IC; Sirimarco, MT; Ziv, Y, 1995) |
| "Bloody bowel movements were common with ulcerative colitis patients and watery diarrhea with Crohn's disease; other findings included abdominal pain, fever, nausea, and vomiting." | 1.29 | Blastocystis hominis in inflammatory bowel disease. ( Brown, M; Nagler, J; Soave, R, 1993) |
| "Three patients with ulcerative colitis in the active stage demonstrated reduced levels of F XIII activity and F XIII subunit A (61 and 80." | 1.28 | Substitution of factor XIII: a therapeutic approach to ulcerative colitis. ( Classen, M; Gain, T; Heinmüller, M; Lorenz, R; Tornieporth, N, 1991) |
| "In six of the nine Crohn's disease patients with an initial Best index of greater than 150, a definite fall by at least 100 points was observed after 2-10 weeks of treatment, but the van Hees index declined only in two patients." | 1.28 | Cyclosporin A treatment in inflammatory bowel disease. ( Ditschuneit, H; Fleig, WE; Rehklau, E; Stange, EF, 1989) |
| "A 43-year-old female suffering from ulcerative colitis did not improve under therapy with sulfasalazine." | 1.27 | Acute ulcerative colitis--a rare complication of sulfasalazine therapy. ( Domschke, S; Ruppin, H, 1984) |
| "A 28-year-old man with chronic ulcerative colitis had a proctocolectomy with creation of a continent ileostomy." | 1.27 | Pouch ileitis: report of a case with severe systemic manifestations. ( Katon, RM; Klein, K; Stenzel, P, 1983) |
| "The remission period of patients with ulcerative colitis was extended by long term treatment with 2-3 g sulphasalazine daily." | 1.26 | [Long-term therapy in ulcerative colitis and Crohn's disease]. ( Malchow, H, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (28.87) | 18.7374 |
| 1990's | 29 (20.42) | 18.2507 |
| 2000's | 26 (18.31) | 29.6817 |
| 2010's | 37 (26.06) | 24.3611 |
| 2020's | 9 (6.34) | 2.80 |
| Authors | Studies |
|---|---|
| Bar, N | 1 |
| Avraham, Y | 1 |
| Dubinsky, V | 1 |
| Cohen, NA | 1 |
| Weiss, GA | 1 |
| Banon, L | 1 |
| Tulchinsky, H | 1 |
| Maharshak, N | 1 |
| Gophna, U | 1 |
| Dotan, I | 1 |
| Poo, S | 1 |
| Sriranganathan, D | 1 |
| Segal, JP | 1 |
| Satka, S | 1 |
| Frybortova, V | 1 |
| Zapletalova, I | 1 |
| Anzenbacher, P | 1 |
| Anzenbacherova, E | 1 |
| Kozakova, H | 1 |
| Srutkova, D | 1 |
| Hudcovic, T | 1 |
| Jourova, L | 1 |
| Barnes, EL | 1 |
| Desai, A | 1 |
| Kochhar, GS | 1 |
| Emile, SH | 1 |
| Horesh, N | 1 |
| Freund, MR | 1 |
| Garoufalia, Z | 1 |
| Gefen, R | 1 |
| Khan, SM | 1 |
| Silva-Alvarenga, E | 1 |
| Wexner, SD | 1 |
| Nguyen, N | 2 |
| Zhang, B | 2 |
| Holubar, SD | 4 |
| Pardi, DS | 5 |
| Singh, S | 3 |
| Barreiro-de Acosta, M | 1 |
| Marín-Jimenez, I | 1 |
| Rodríguez-Lago, I | 1 |
| Guarner, F | 1 |
| Espín, E | 1 |
| Ferrer Bradley, I | 1 |
| Gutiérrez, A | 1 |
| Beltrán, B | 1 |
| Chaparro, M | 1 |
| Gisbert, JP | 1 |
| Nos, P | 1 |
| Mishra, S | 1 |
| Mandavdhare, HS | 1 |
| Singh, H | 1 |
| Choudhury, A | 1 |
| Shah, J | 1 |
| Ram, S | 1 |
| Kalsi, D | 1 |
| Samanta, J | 1 |
| Prasad, KK | 1 |
| Sharma, AK | 1 |
| Dutta, U | 1 |
| Sharma, V | 1 |
| Kayal, M | 1 |
| Bhagya Rao, B | 1 |
| Bhattacharya, A | 1 |
| Ungaro, R | 1 |
| Petridou, C | 1 |
| Al-Badri, A | 1 |
| Dua, A | 1 |
| Dryden, M | 1 |
| Saeed, K | 1 |
| Theochari, NA | 1 |
| Stefanopoulos, A | 1 |
| Mylonas, KS | 1 |
| Economopoulos, KP | 1 |
| Nishii, S | 1 |
| Higashiyama, M | 1 |
| Ogata, S | 1 |
| Komoto, S | 1 |
| Ito, S | 2 |
| Mizoguchi, A | 1 |
| Terada, H | 1 |
| Furuhashi, H | 1 |
| Takajo, T | 1 |
| Shirakabe, K | 1 |
| Watanabe, C | 1 |
| Tomita, K | 1 |
| Nagao, S | 1 |
| Miura, S | 1 |
| Hokari, R | 1 |
| Kordy, K | 1 |
| Romeo, AC | 1 |
| Lee, DJ | 1 |
| Li, F | 1 |
| Zabih, S | 1 |
| Saavedra, M | 1 |
| Cunningham, NJ | 1 |
| Tobin, N | 1 |
| Aldrovandi, GM | 1 |
| Ishikawa, D | 2 |
| Sasaki, T | 2 |
| Takahashi, M | 1 |
| Kuwahara-Arai, K | 2 |
| Haga, K | 2 |
| Okahara, K | 1 |
| Nakajima, A | 1 |
| Shibuya, T | 2 |
| Osada, T | 2 |
| Hiramatsu, K | 2 |
| Watanabe, S | 3 |
| Nagahara, A | 1 |
| Little, K | 1 |
| Argollo, M | 1 |
| Kotze, PG | 1 |
| Lamonaca, L | 1 |
| Gilardi, D | 1 |
| Furfaro, F | 1 |
| Yamamoto, T | 1 |
| Danese, S | 1 |
| Troelsen, FS | 1 |
| Jick, S | 1 |
| Meyer, C | 1 |
| Bowers, A | 1 |
| Heavener, TE | 1 |
| Checketts, JX | 1 |
| Vassar, M | 1 |
| Benlice, C | 1 |
| Shen, B | 3 |
| Steele, SR | 1 |
| Samaha, M | 1 |
| Moloney, M | 1 |
| Oshima, T | 1 |
| Takesue, Y | 2 |
| Ikeuchi, H | 3 |
| Matsuoka, H | 2 |
| Nakajima, K | 1 |
| Uchino, M | 3 |
| Tomita, N | 2 |
| Sasako, M | 1 |
| Guslandi, M | 1 |
| Koido, S | 1 |
| Ohkusa, T | 9 |
| Kajiura, T | 1 |
| Shinozaki, J | 1 |
| Suzuki, M | 1 |
| Saito, K | 1 |
| Takakura, K | 1 |
| Tsukinaga, S | 1 |
| Odahara, S | 1 |
| Yukawa, T | 1 |
| Mitobe, J | 1 |
| Kajihara, M | 1 |
| Uchiyama, K | 1 |
| Arakawa, H | 1 |
| Tajiri, H | 3 |
| Kato, K | 4 |
| Terao, S | 3 |
| Chiba, T | 2 |
| Murakami, K | 3 |
| Yanaka, A | 2 |
| Uehara, T | 2 |
| Ishii, Y | 2 |
| Soma, M | 1 |
| Pierce, D | 1 |
| Corcoran, M | 1 |
| Martin, P | 1 |
| Barrett, K | 1 |
| Inglis, S | 1 |
| Preston, P | 1 |
| Thompson, TN | 1 |
| Willsie, SK | 1 |
| Turner, D | 1 |
| Levine, A | 1 |
| Kolho, KL | 1 |
| Shaoul, R | 1 |
| Ledder, O | 1 |
| Stroud, AM | 1 |
| Sandborn, WJ | 3 |
| Den, Y | 1 |
| Kinoshita, J | 1 |
| Deshpande, GA | 1 |
| Hiraoka, E | 1 |
| Kikuchi, S | 1 |
| Orii, F | 1 |
| Maemoto, A | 1 |
| Ashida, T | 1 |
| Ozdemir, S | 1 |
| Gulpinar, K | 1 |
| Ozis, SE | 1 |
| Sahli, Z | 1 |
| Kesikli, SA | 1 |
| Korkmaz, A | 1 |
| Gecim, IE | 1 |
| Peixoto, A | 1 |
| Silva, M | 1 |
| Vilas-Boas, F | 1 |
| Macedo, G | 1 |
| Nomura, K | 1 |
| Fujimoto, Y | 1 |
| Yamashita, M | 1 |
| Morimoto, Y | 1 |
| Ohshiro, M | 1 |
| Sato, K | 1 |
| Oyake, T | 1 |
| Kowata, S | 1 |
| Konishi, H | 1 |
| Yoshikawa, T | 1 |
| Ishida, Y | 1 |
| Taniwaki, M | 1 |
| Nishikawa, J | 1 |
| Kudo, T | 1 |
| Sakata, S | 1 |
| Benno, Y | 2 |
| Sugiyama, T | 2 |
| McLaughlin, SD | 1 |
| Clark, SK | 1 |
| Bell, AJ | 1 |
| Tekkis, PP | 1 |
| Ciclitira, PJ | 1 |
| Nicholls, RJ | 2 |
| He, X | 1 |
| Bennett, AE | 1 |
| Lian, L | 1 |
| Mabe, K | 1 |
| Mizokami, Y | 1 |
| Takeuchi, Y | 1 |
| Yamato, S | 1 |
| Yokoyama, T | 1 |
| Okayasu, I | 4 |
| Sato, N | 3 |
| Cima, RR | 1 |
| Sugitani, M | 1 |
| Nemoto, N | 1 |
| Moriyama, M | 1 |
| Tai, WP | 1 |
| Hu, PJ | 1 |
| Wu, J | 1 |
| Lin, XC | 1 |
| Yamashiro, K | 1 |
| Tamura, I | 1 |
| Hirano, T | 1 |
| Ott, C | 1 |
| Girlich, C | 1 |
| Klebl, F | 1 |
| Plentz, A | 1 |
| Iesalnieks, I | 1 |
| Schölmerich, J | 2 |
| Obermeier, F | 1 |
| Na, DK | 1 |
| Kim, JB | 1 |
| Shin, YC | 1 |
| Shin, SL | 1 |
| Kim, HJ | 1 |
| Baek, IH | 1 |
| Park, SH | 1 |
| Lee, MS | 1 |
| Kim, MJ | 1 |
| Jang, KT | 1 |
| Choe, YH | 1 |
| Suzuki, H | 1 |
| Ogawa, H | 1 |
| Shibata, C | 1 |
| Haneda, S | 1 |
| Watanabe, K | 1 |
| Takahashi, K | 1 |
| Funayama, Y | 1 |
| Sasaki, I | 1 |
| Tursi, A | 1 |
| Elisei, W | 1 |
| Brandimarte, G | 1 |
| Giorgetti, GM | 1 |
| Inchingolo, CD | 1 |
| Nenna, R | 1 |
| Picchio, M | 1 |
| Giorgio, F | 1 |
| Ierardi, E | 1 |
| Bando, T | 1 |
| Chiba, M | 1 |
| Abe, T | 1 |
| Tsuda, S | 1 |
| Ono, I | 1 |
| Nakano, H | 1 |
| Nakamura, M | 1 |
| Yanagi, H | 1 |
| Noda, M | 1 |
| Yamamura, T | 1 |
| Gosselink, MP | 1 |
| Schouten, WR | 1 |
| van Lieshout, LM | 1 |
| Hop, WC | 1 |
| Laman, JD | 1 |
| Ruseler-van Embden, JG | 1 |
| Herrlinger, K | 1 |
| Stange, EF | 2 |
| Miner, J | 1 |
| Gillan, MM | 1 |
| Alex, P | 1 |
| Centola, M | 1 |
| Nedin, D | 2 |
| Aleksandrova, A | 2 |
| Ohge, H | 1 |
| Furne, JK | 1 |
| Springfield, J | 1 |
| Rothenberger, DA | 1 |
| Madoff, RD | 1 |
| Levitt, MD | 1 |
| Nomura, T | 2 |
| Yoshida, T | 2 |
| Sakamoto, M | 1 |
| Hayashi, H | 1 |
| Hirai, S | 2 |
| Hojo, M | 2 |
| Kobayashi, O | 2 |
| Terai, T | 2 |
| Miwa, H | 2 |
| Takei, Y | 2 |
| Ogihara, T | 2 |
| Gionchetti, P | 2 |
| Rizzello, F | 2 |
| Morselli, C | 1 |
| Romagnoli, R | 1 |
| Campieri, M | 2 |
| De Bleecker, JL | 1 |
| Leroy, BP | 1 |
| Meire, VI | 1 |
| Okazaki, K | 1 |
| Matsushita, M | 1 |
| Kawamata, S | 1 |
| Shimatani, M | 1 |
| Fujii, T | 1 |
| Tsironi, E | 1 |
| Irving, PM | 1 |
| Feakins, RM | 1 |
| Rampton, DS | 2 |
| Tremaine, WJ | 1 |
| Tsesmeli, NE | 1 |
| Giannoulis, KE | 1 |
| Savopoulos, CG | 1 |
| Vretou, EE | 1 |
| Ekonomou, IA | 1 |
| Giannoulis, EK | 1 |
| Riis, P | 1 |
| Singleton, JW | 1 |
| Ewe, K | 1 |
| Karbach, U | 1 |
| Gilat, T | 3 |
| Järnerot, G | 1 |
| Goldstein, F | 1 |
| Ruppin, H | 1 |
| Domschke, S | 1 |
| Malchow, H | 2 |
| Ambrose, NS | 1 |
| Alexander-Williams, J | 1 |
| Keighley, MR | 2 |
| Fukuda, H | 1 |
| Ide, T | 1 |
| Ichimura, T | 1 |
| Haraguchi, M | 1 |
| Mori, N | 1 |
| Makiyama, K | 1 |
| Saito, A | 1 |
| Hara, K | 1 |
| Klein, K | 1 |
| Stenzel, P | 1 |
| Katon, RM | 1 |
| Hares, MM | 1 |
| Bentley, S | 1 |
| Allan, RN | 1 |
| Burdon, DW | 1 |
| Thiel, H | 1 |
| Ecker, KW | 1 |
| Kojima, T | 1 |
| Nakamura, T | 1 |
| Aoki, Y | 1 |
| Tomita, E | 1 |
| Stein, BL | 1 |
| Gordon, PH | 1 |
| Lavery, IC | 1 |
| Sirimarco, MT | 1 |
| Ziv, Y | 1 |
| Fazio, VW | 2 |
| Sachar, DB | 2 |
| Mignon, M | 2 |
| Stettler, C | 2 |
| Phillips, SF | 2 |
| van Hogezand, RA | 2 |
| Lamers, CB | 1 |
| Nygaard, K | 1 |
| Bergan, T | 1 |
| Bjørneklett, A | 1 |
| Høverstad, T | 1 |
| Lassen, J | 1 |
| Aase, S | 1 |
| Madden, MV | 1 |
| McIntyre, AS | 1 |
| Chaussade, S | 1 |
| Mantzaris, GJ | 1 |
| Hatzis, A | 1 |
| Kontogiannis, P | 1 |
| Triadaphyllou, G | 1 |
| Menzel, J | 1 |
| Bauer, J | 1 |
| von Pritzbuer, E | 1 |
| Klempa, I | 1 |
| Nagler, J | 1 |
| Brown, M | 1 |
| Soave, R | 1 |
| Hurst, RD | 1 |
| Molinari, M | 1 |
| Chung, TP | 1 |
| Rubin, M | 1 |
| Michelassi, F | 1 |
| Bonner, GF | 1 |
| Castro, M | 1 |
| Rosati, P | 1 |
| Lucidi, V | 1 |
| Scotta, MS | 1 |
| Papadatou, B | 1 |
| Hadorn, HB | 1 |
| McCaulley, ME | 1 |
| Keränen, U | 1 |
| Luukkonen, P | 1 |
| Järvinen, H | 1 |
| Wyllie, R | 1 |
| Sarigol, S | 1 |
| Arimura, Y | 1 |
| Endo, T | 1 |
| Imai, K | 1 |
| Stein, RB | 1 |
| Lichtenstein, GR | 1 |
| Balbir-Gurman, A | 1 |
| Schapira, D | 1 |
| Nahir, M | 1 |
| Parlak, E | 1 |
| Dağli, U | 1 |
| Ulker, A | 1 |
| Alkim, C | 1 |
| Sahin, B | 1 |
| Achkar, JP | 1 |
| Lashner, BA | 1 |
| Ormsby, AH | 1 |
| Remzi, FH | 1 |
| Brzezinski, A | 1 |
| Bevins, CL | 1 |
| Bambrick, ML | 1 |
| Seidner, DL | 1 |
| Madiba, TE | 1 |
| Bartolo, DC | 1 |
| Amadini, C | 1 |
| Venturi, A | 1 |
| Matuchansky, C | 1 |
| Cavell, B | 1 |
| Hildebrand, H | 1 |
| Meeuwisse, GW | 1 |
| Lindquist, B | 1 |
| Lennard-Jones, JE | 1 |
| Powell-Tuck, J | 1 |
| Hilmer, R | 1 |
| Goulston, K | 1 |
| Sunarwan, I | 1 |
| Rosekrans, PC | 1 |
| Onderdonk, AB | 1 |
| Hermos, JA | 1 |
| Dzink, JL | 1 |
| Bartlett, JG | 1 |
| Present, DH | 1 |
| Yamada, M | 2 |
| Lorenz, R | 1 |
| Heinmüller, M | 1 |
| Classen, M | 1 |
| Tornieporth, N | 1 |
| Gain, T | 1 |
| McCarthy, DA | 1 |
| Liu, YC | 1 |
| Feurle, GE | 1 |
| Jeddy, TA | 1 |
| Farrington, GH | 1 |
| Rasenack, J | 1 |
| Kreisel, W | 1 |
| Fellhauer, M | 1 |
| Dubé, S | 1 |
| Heyen, F | 1 |
| Lloyd-Still, JD | 1 |
| Takenaga, T | 1 |
| Kitazume, C | 1 |
| Yamamoto, N | 1 |
| Sasabe, M | 1 |
| Takashimizu, I | 1 |
| Tamura, Y | 1 |
| Sakamoto, E | 1 |
| Kurosawa, H | 1 |
| Gitnick, G | 1 |
| Leichtman, G | 2 |
| Delpre, G | 2 |
| Eshchar, J | 1 |
| Bar Meir, S | 1 |
| Fireman, Z | 2 |
| Fleig, WE | 1 |
| Rehklau, E | 1 |
| Ditschuneit, H | 1 |
| Korelitz, BI | 1 |
| Nagy, G | 1 |
| Prónay, G | 1 |
| Ujszászy, L | 1 |
| Shaffer, JL | 1 |
| Kershaw, A | 1 |
| Houston, JB | 1 |
| Gerok, W | 1 |
| Ruderman, WB | 1 |
| Farmer, RG | 1 |
| Suissa, A | 1 |
| Pavlotzky, M | 1 |
| Grossman, A | 1 |
| Sutherland, LR | 1 |
| Dölle, W | 1 |
| Daiss, W | 1 |
| Okada, M | 1 |
| Yao, T | 1 |
| Chapman, RW | 1 |
| Selby, WS | 1 |
| Jewell, DP | 1 |
| McCulloch, AJ | 1 |
| McEvoy, A | 1 |
| Jackson, JD | 1 |
| Jarvis, EH | 1 |
| Miller, B | 1 |
| Martini, GA | 1 |
| Pittman, FE | 1 |
| el-Hashimi, WK | 1 |
| Pittman, JC | 1 |
| Balikian, JP | 1 |
| Uthman, SM | 1 |
| Khouri, NF | 1 |
| Tanimoto-Weki, M | 1 |
| Delgado-Carnica, R | 1 |
| López-Mora, G | 1 |
| Ramírez-Degollado, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "A Phase 1b/2 Study to Demonstrate the Safety and Efficacy of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an Ileal Pouch-Anal Anastomosis (PROF). The PROF Study."[NCT05938465] | Phase 1/Phase 2 | 50 participants (Anticipated) | Interventional | 2023-10-11 | Recruiting | ||
| Use of Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis: A Randomised Trial[NCT03794765] | Phase 2 | 50 participants (Actual) | Interventional | 2019-04-01 | Completed | ||
| Antimicrobial Therapy for Ulcerative Colitis : Evaluation of Two Antibiotic Combinations for Refractory Ulcerative Colitis[NCT03986996] | Phase 2 | 20 participants (Actual) | Interventional | 2019-07-25 | Terminated (stopped due to There is no feasibility to conduct the study) | ||
| A Phase 1, Randomized, Open-label, Crossover, Drug Interaction Study Evaluating the Pharmacokinetic Profiles of Amoxicillin Administered Alone and in Combination With MMX® Mesalazine/Mesalamine in Healthy Adult Subjects[NCT01442688] | Phase 1 | 62 participants (Actual) | Interventional | 2011-10-07 | Completed | ||
| A Phase 1, Randomized, Open-label, Crossover, Drug Interaction Study Evaluating the Pharmacokinetic Profiles of Sulfamethoxazole Administered Alone and in Combination With MMX® Mesalazine/Mesalamine in Healthy Adult Subjects[NCT01469637] | Phase 1 | 44 participants (Actual) | Interventional | 2011-11-07 | Completed | ||
| A Phase 1, Randomized, Open-label, Crossover, Drug Interaction Study Evaluating the Pharmacokinetic Profiles of Ciprofloxacin XR Administered Alone and in Combination With MMX® Mesalazine/Mesalamine in Healthy Adult Subjects[NCT01402947] | Phase 1 | 30 participants (Actual) | Interventional | 2011-07-25 | Completed | ||
| A Phase 1, Randomized, Open-label, Crossover, Drug Interaction Study Evaluating the Pharmacokinetic Profiles of Metronidazole Administered Alone and in Combination With MMX® Mesalazine/Mesalamine in Healthy Adult Subjects[NCT01418365] | Phase 1 | 30 participants (Actual) | Interventional | 2011-08-22 | Completed | ||
| Precision Medicine in Systemic Sclerosis Gastrointestinal Disease: Evaluating Imaging and Stool Biomarkers for Differentiating Disease Stages and Treatment Responses[NCT04630782] | 70 participants (Anticipated) | Observational | 2020-04-09 | Recruiting | |||
| A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis[NCT00583531] | Phase 2 | 2 participants (Actual) | Interventional | 2007-03-31 | Terminated (stopped due to Lack of enrollment) | ||
| A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Active Pouchitis[NCT00583076] | Phase 2 | 19 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
| Fecal Microbiota Transplantation for the Treatment of Chronic Pouchitis[NCT03538366] | 10 participants (Actual) | Interventional | 2018-05-15 | Completed | |||
| Randomized, Double-Blind, Placebo-Controlled Study of VSL#3 Versus Placebo in the Maintenance of Remission in Crohn's Disease[NCT00114465] | Phase 4 | 38 participants (Actual) | Interventional | 2005-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
AUC can be used as a measure of drug exposure. It is derived from drug concentration and time so it gives a measure how much and how long a drug stays in a body. (NCT01442688)
Timeframe: Assessed over a 24-hour period starting post-dose on day 4
| Intervention | h*ug/ml (Mean) |
|---|---|
| Amoxicillin + MMX Placebo | 27.8 |
| Amoxicillin + MMX Mesalazine/Mesalamine | 28.3 |
Cmax is a term that refers to the maximum (or peak) concentration that a drug achieves in the body after the drug has been administrated. (NCT01442688)
Timeframe: Assessed over a 24-hour period starting post-dose on day 4
| Intervention | ug/ml (Mean) |
|---|---|
| Amoxicillin + MMX Placebo | 10.3 |
| Amoxicillin + MMX Mesalazine/Mesalamine | 10.2 |
AUC can be used as a measure of drug exposure. It is derived from drug concentration and time so it gives a measure of how much and how long a drug stays in a body. (NCT01469637)
Timeframe: Assessed over a 24-hour period starting post-dose on day 4
| Intervention | h*ug/ml (Mean) |
|---|---|
| Sulfamethoxazole + MMX Placebo | 786 |
| Sulfamethoxazole + MMX Mesalazine/Mesalamine | 909 |
Cmax is a term that refers to the maximum (or peak) concentration that a drug achieves in the body after the drug has been administrated. (NCT01469637)
Timeframe: Assessed over a 24-hour period starting post-dose on day 4
| Intervention | ug/ml (Mean) |
|---|---|
| Sulfamethoxazole + MMX Placebo | 89.1 |
| Sulfamethoxazole + MMX Mesalazine/Mesalamine | 100 |
AUC can be used as a measure of drug exposure. It is derived from drug concentration and time so it gives a measure how much and how long a drug stays in a body. (NCT01402947)
Timeframe: Assessed over a 24-hour period starting post-dose on day 4
| Intervention | ng*h/ml (Mean) |
|---|---|
| MMX Placebo + Ciprofloxacin | 7805 |
| MMX Mesalazine/Mesalamine + Ciprofloxacin | 7934 |
Cmax is a term that refers to the maximum (or peak) concentration that a drug achieves in the body after the drug has been administrated. (NCT01402947)
Timeframe: Assessed over a 24-hour period starting post-dose on day 4
| Intervention | ng/ml (Mean) |
|---|---|
| MMX Placebo + Ciprofloxacin | 1455 |
| MMX Mesalazine/Mesalamine + Ciprofloxacin | 1433 |
AUC can be used as a measure of drug exposure. It is derived from drug concentration and time so it gives a measure how much and how long a drug stays in a body. (NCT01418365)
Timeframe: Assessed over a 24-hour period starting post-dose on day 4
| Intervention | ng*h/ml (Mean) |
|---|---|
| Metronidazole + MMX Placebo | 217686 |
| Metronidazole + MMX Mesalazine/Mesalamine | 215809 |
Cmax is a term that refers to the maximum (or peak) concentration that a drug achieves in the body after the drug has been administrated. (NCT01418365)
Timeframe: Assessed over a 24-hour period starting post-dose on day 4
| Intervention | ng/ml (Mean) |
|---|---|
| Metronidazole + MMX Placebo | 28193 |
| Metronidazole + MMX Mesalazine/Mesalamine | 28057 |
35 reviews available for metronidazole and Colitis Gravis
| Article | Year |
|---|---|
Network meta-analysis: efficacy of treatment for acute, chronic, and prevention of pouchitis in ulcerative colitis.
Topics: Anti-Bacterial Agents; Colitis, Ulcerative; Humans; Metronidazole; Network Meta-Analysis; Pouchitis; | 2022 |
A Systematic Review and Meta-analysis of Randomized Clinical Trials on the Prevention and Treatment of Pouchitis after Ileoanal Pouch Anastomosis.
Topics: Anastomosis, Surgical; Ciprofloxacin; Colitis, Ulcerative; Humans; Metronidazole; Pouchitis; Proctoc | 2023 |
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
Topics: Anastomosis, Surgical; Anti-Bacterial Agents; Budesonide; Ciprofloxacin; Colitis, Ulcerative; Enema; | 2019 |
Antibiotics exposure and risk of inflammatory bowel disease: a systematic review.
Topics: Anti-Bacterial Agents; Colitis, Ulcerative; Crohn Disease; Fluoroquinolones; Humans; Metronidazole; | 2018 |
Prevention of Postoperative Recurrence in CD: Tailoring Treatment to Patient Profile.
Topics: Ciprofloxacin; Colitis, Ulcerative; Humans; Metronidazole; Patient-Centered Care; Pouchitis; Practic | 2019 |
Prevention and Medical Treatment of Pouchitis In Ulcerative Colitis.
Topics: Anti-Bacterial Agents; Budesonide; Ciprofloxacin; Colitis, Ulcerative; Humans; Male; Metronidazole; | 2019 |
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
Topics: Adult; Budesonide; Ciprofloxacin; Colitis, Ulcerative; Enema; Gastrointestinal Agents; Humans; Metro | 2015 |
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
Topics: Adult; Ciprofloxacin; Colitis, Ulcerative; Enema; Gastrointestinal Agents; Humans; Metronidazole; Po | 2010 |
[Chronic inflammatory bowel diseases].
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Infective Agents; | 2004 |
[Pancreatitis accompanying inflammatory bowel diseases, and our observations].
Topics: Acute Disease; Amylases; Anti-Infective Agents; Anti-Inflammatory Agents; Bulgaria; Cholangitis, Scl | 2004 |
Management of inflammatory bowel disease: does rifaximin offer any promise?
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Clinical Trials as Topic; Colitis, Ulcerative; Crohn | 2005 |
[Diagnosis and medical treatment of pouchitis in ileal pouch-anal anastomosis in patients with ulcerative colitis].
Topics: Acute Disease; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Humans; Immunologic Factor | 2005 |
A critical survey of controlled studies in the treatment of ulcerative colitis and Crohn's disease.
Topics: BCG Vaccine; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cromolyn Sodium; Glucocor | 1980 |
Fertility, sterility, and pregnancy in chronic inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Colitis, Ulcerative; Crohn Disease; Female; Fertility; Humans; Infant, Newb | 1982 |
Perianal inflammatory conditions in inflammatory bowel disease.
Topics: Abscess; Adult; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Female; Humans; Male; | 1993 |
Maintenance therapy in ulcerative colitis and Crohn's disease.
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents; Col | 1995 |
Pouchitis--a poorly understood entity.
Topics: Anal Canal; Anastomosis, Surgical; Colitis, Ulcerative; Humans; Inflammatory Bowel Diseases; Metroni | 1995 |
[Possibilities of drug treatment in inflammatory intestinal diseases].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, | 1994 |
Medical management of patients with difficult-to-treat inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine | 1994 |
[Ileo-anal "pouchitis": a still misunderstood pathology].
Topics: Adrenal Cortex Hormones; Colitis, Ulcerative; Glutamine; Humans; Ileitis; Inflammation; Metronidazol | 1993 |
[Ileoanal anastomosis with pouch: a rigorous surgical technique is necessary, but the most frequent long-term postoperative complication remains inflammation of the pouch].
Topics: Adenomatous Polyposis Coli; Adrenal Cortex Hormones; Colitis, Ulcerative; Diarrhea; Female; Humans; | 1993 |
Current medical therapy for inflammatory bowel disease.
Topics: Administration, Topical; Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Anti-In | 1996 |
The treatment of inflammatory bowel disease in children.
Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Child; Colitis, Ulcerative; Crohn Disease; Fe | 1998 |
[Therapeutic strategy for severe and fulminating ulcerative colitis].
Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Colectomy; Colitis, Ulcerative; Cyclosporine; | 1999 |
Complications after ileal pouch-anal anastomosis.
Topics: Anastomosis, Surgical; Ciprofloxacin; Colitis, Ulcerative; Crohn Disease; Humans; Male; Metronidazol | 2000 |
Review article: treatment of mild to moderate ulcerative colitis and pouchitis.
Topics: Administration, Oral; Administration, Rectal; Anti-Infective Agents; Anti-Inflammatory Agents; Anti- | 2002 |
Drug treatment of inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Antidiarrheals; Azathio | 1979 |
Immunotherapy in inflammatory bowel disease.
Topics: Adult; Alkylating Agents; Antimetabolites; Azathioprine; Child; Clinical Trials as Topic; Colitis, U | 1978 |
[New developments in the treatment of inflammatory bowel diseases. What is certain?].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Immunosu | 1990 |
[Conservative therapy of ulcerative colitis and Crohn disease].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Humans; Immunosup | 1991 |
Antibiotics and inflammatory bowel diseases.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Colitis, Ulcerative; Croh | 1989 |
Current management of inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aza Compounds; Colitis, Ulcerative; Combined Modality Therapy; Crohn Diseas | 1987 |
Medical treatment of inflammatory bowel disease: new therapies, new drugs.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; F | 1987 |
[Therapy of chronic inflammatory bowel diseases. Clinical aspects and therapy of drug-induced side effects].
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive | 1988 |
[What is secured in the therapy of chronic inflammatory colonic diseases?].
Topics: Administration, Topical; Amebiasis; Azathioprine; Chronic Disease; Colitis; Colitis, Ulcerative; Col | 1974 |
30 trials available for metronidazole and Colitis Gravis
| Article | Year |
|---|---|
Adjuvant use of combination of antibiotics in acute severe ulcerative colitis: A placebo controlled randomized trial.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Ceftriaxone; Colitis, Ulcerative; Double-Blind Method; | 2021 |
Preoperative oral antibiotics and intravenous antimicrobial prophylaxis reduce the incidence of surgical site infections in patients with ulcerative colitis undergoing IPAA.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anal Canal; Anastomosis, Surgical; Anti-Ba | 2013 |
Long-term alteration of intestinal microbiota in patients with ulcerative colitis by antibiotic combination therapy.
Topics: Actins; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Colitis, Ulcerative; Double-Bli | 2014 |
Adjunct antibiotic combination therapy for steroid-refractory or -dependent ulcerative colitis: an open-label multicentre study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Colectomy; Colitis, Ulcerative; Colonos | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Femal | 2014 |
Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Colitis, Ulcerative; Colon; Colonoscopy; Combined M | 2017 |
Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Amoxicillin; Colitis, Ulcerative; Double-Blind | 2010 |
Efficacy of antibiotic combination therapy in patients with active ulcerative colitis, including refractory or steroid-dependent cases.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biomarkers; Colitis, Ulcerative; Colon; Colonoscopy; Drug | 2010 |
Antibiotic combination therapy for steroid withdrawal in steroid-dependent ulcerative colitis.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Drug | 2011 |
Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clostridium Infections; Clostridium perfringens; Coliti | 2004 |
Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clostridium Infections; Clostridium perfringens; Coliti | 2004 |
Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clostridium Infections; Clostridium perfringens; Coliti | 2004 |
Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clostridium Infections; Clostridium perfringens; Coliti | 2004 |
Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy.
Topics: Amoxicillin; Colitis, Ulcerative; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections | 2005 |
Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized, controlled pilot trial with long-term follow-up.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Colitis, Ulcerative; Dose-Response Relationsh | 2005 |
A critical survey of controlled studies in the treatment of ulcerative colitis and Crohn's disease.
Topics: BCG Vaccine; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cromolyn Sodium; Glucocor | 1980 |
Metronidazole in Crohn's disease.
Topics: Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Humans; Metronida | 1982 |
Audit of sepsis in operations for inflammatory bowel disease.
Topics: Abscess; Adult; Colitis, Ulcerative; Crohn Disease; Female; Gentamicins; Humans; Male; Metronidazole | 1984 |
Clinical trials of the efficacy and duration of antibacterial cover for elective resection in inflammatory bowel disease.
Topics: Adult; Bacterial Infections; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Double-Bl | 1982 |
Topical metronidazole treatment in pouchitis.
Topics: Adenomatous Polyposis Coli; Administration, Topical; Adolescent; Adult; Colitis, Ulcerative; Fatty A | 1994 |
Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis.
Topics: C-Reactive Protein; Chronic Disease; Colitis, Ulcerative; Defecation; Double-Blind Method; Humans; I | 1994 |
Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Colitis, Ulcerative; Drug Therapy, C | 1994 |
[Perioperative use of ampicillin/sulbactam, cefoxitin and piperacillin/ metronidazole in elective colon and rectal surgery. A prospective randomized quality assurance study of 422 patients].
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cefoxitin; Colitis, Ulcerative; Colon | 1993 |
Comparison of 5-amino salicylic acid plus glucocorticosteroid with metronidazole and ciprofloxacin in patients with active ulcerative colitis.
Topics: Adult; Ciprofloxacin; Colitis, Ulcerative; Drug Therapy, Combination; Female; Glucocorticoids; Human | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female; Humans; Mal | 2001 |
Drug treatment of inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Antidiarrheals; Azathio | 1979 |
Immunotherapy in inflammatory bowel disease.
Topics: Adult; Alkylating Agents; Antimetabolites; Azathioprine; Child; Clinical Trials as Topic; Colitis, U | 1978 |
[New developments in the treatment of inflammatory bowel diseases. What is certain?].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Immunosu | 1990 |
Azathioprine and the treatment of chronic inflammatory bowel disease.
Topics: Adolescent; Adult; Azathioprine; Child; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Hum | 1990 |
A comparison of metronidazole and sulfasalazine in the maintenance of remission in patients with ulcerative colitis.
Topics: Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Female; Follow-Up Studies; Human | 1989 |
[Drug therapy of chronic inflammatory intestinal diseases--current status of 5-aminosalicylic acid].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Colitis, Ulce | 1986 |
A comparative study of metronidazole and sulfasalazine in active, not severe, ulcerative colitis. An Israeli multicenter trial.
Topics: Acute Disease; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Female; Humans; I | 1987 |
Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Drug Th | 1986 |
81 other studies available for metronidazole and Colitis Gravis
| Article | Year |
|---|---|
Long-term Antibiotic Treatment in Pouchitis-Patterns of Use and Safety.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colitis, Ulcerative; Humans; Metronidazole; Pouchitis; Proctoc | 2022 |
Effect of DSS-Induced Ulcerative Colitis and Butyrate on the Cytochrome P450 2A5: Contribution of the Microbiome.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Butyrates; Colitis, Ulcerative; Cytochrome | 2022 |
The Comparative Effectiveness of Ciprofloxacin and Metronidazole for an Initial Episode of Pouchitis: A Propensity-Matched Study.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colitis, Ulcerative; Humans; Male; Metronidazole; Pouchitis; P | 2023 |
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment.
Topics: Acute Disease; Advisory Committees; Algorithms; Anti-Bacterial Agents; Biological Products; Budesoni | 2020 |
Clinical Challenge: From Ulcerative Colitis to Crohn's Disease-Like Pouch Inflammation.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Colitis, Ulcerative; Crohn Di | 2021 |
Learning points from a case of severe amoebic colitis.
Topics: Colitis, Ulcerative; Combined Modality Therapy; Delayed Diagnosis; Diagnosis, Differential; Diagnost | 2017 |
Human intestinal spirochetosis mimicking ulcerative colitis.
Topics: Aged; Anti-Infective Agents; Brachyspira; Colitis; Colitis, Ulcerative; Colonoscopy; Diagnosis, Diff | 2018 |
Combination Antibiotics Improves Disease Activity and Alters Microbial Communities in Children With Ulcerative Colitis.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Child; Colitis, Ulcerative; Doxycycline; Fema | 2018 |
The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteroidetes; Colitis, Ulcerative; Combined Modality Therapy; D | 2018 |
What is causing this patient's multiple skin abscesses?
Topics: Abscess; Adolescent; Colitis, Ulcerative; Cyclosporine; Dermatologic Agents; Female; Gastrointestina | 2018 |
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
Topics: Anastomosis, Surgical; Anti-Bacterial Agents; Budesonide; Ciprofloxacin; Colitis, Ulcerative; Enema; | 2019 |
Antibiotic Use in Childhood and Adolescence and Risk of Inflammatory Bowel Disease: A Case-Control Study in the UK Clinical Practice Research Datalink.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Colit | 2020 |
From clinical practice guideline development to trial registration: A systematic investigation of research pipeline for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Bibliometrics; Biomedical Research; Clinical Trials | 2019 |
Long-term antibiotic therapy in late onset pouch-urethral fistula after ileoanal anastomosis for ulcerative colitis may be effective and well tolerated.
Topics: Adult; Anal Canal; Anastomosis, Surgical; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; | 2013 |
Role of probiotics in the management of pouchitis.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Colitis, Ulcerative; Humans; Intestines; Metronidazol | 2014 |
Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; C-Reactive Protein; Child; Colitis, Ulcerative; Doxy | 2014 |
Amoebiasis masquerading as inflammatory bowel disease.
Topics: Antiprotozoal Agents; Colitis, Ulcerative; Diagnosis, Differential; Diagnostic Errors; Diarrhea; Dys | 2015 |
Reversible Posterior Leukoencephalopathy Syndrome Associated with Treatment for Acute Exacerbation of Ulcerative Colitis.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Blood Transfusion; Colitis, Ulcerative; Contraindic | 2016 |
The effects of preoperative oral antibiotic use on the development of surgical site infection after elective colorectal resections: A retrospective cohort analysis in consecutively operated 90 patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anastomotic Leak; Anti-Bacterial Agents; Antib | 2016 |
All that glitters is not gold. A different cause for an "ulcerative colitis".
Topics: Adult; Antitrichomonal Agents; Colitis, Ulcerative; Entamoeba histolytica; Entamoebiasis; Humans; Ma | 2017 |
[Intestinal parasitoses and worm infestations].
Topics: Amebiasis; Antiprotozoal Agents; Colitis, Ulcerative; Diagnosis, Differential; Dysentery, Amebic; En | 2008 |
Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Clostridioides di | 2009 |
Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Case-Control Studies; Colitis, U | 2009 |
Incidence and short-term implications of prepouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Budesonide; Ciprofloxacin; Colitis, Ul | 2009 |
Recurrent cytomegalovirus infection in ileal pouch-anal anastomosis for ulcerative colitis.
Topics: Ciprofloxacin; Colitis, Ulcerative; Colonic Pouches; Cytomegalovirus Infections; Dietary Supplements | 2010 |
Six ulcerative colitis patients with refractory symptoms co-infective with Blastocystis hominis in China.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiprotozoal Agents; Blastocystis hominis; Blastocy | 2011 |
Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Azathiop | 2011 |
[Left-sided ulcerative colitis reactivated and aggravated during clostridium difficile infection].
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Clostridioides d | 2011 |
Azathioprine hypersensitivity presenting as sweet syndrome in a child with ulcerative colitis.
Topics: Azathioprine; Child; Colitis, Ulcerative; Drug Hypersensitivity; Female; Humans; Immunosuppressive A | 2011 |
The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Colonic Pou | 2012 |
Mucosal expression of basic fibroblastic growth factor, Syndecan 1 and tumor necrosis factor-alpha in diverticular disease of the colon: a case-control study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Case | 2012 |
Clinical features and management of pouchitis in Japanese ulcerative colitis patients.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Age of Onset; Aged; Anti-Bacterial Agents; Asian Peop | 2013 |
Cytomegalovirus infection associated with onset of ulcerative colitis.
Topics: Adult; Aged; Anti-Infective Agents; Colitis, Ulcerative; Cytomegalovirus Infections; Female; Gastroi | 2013 |
Incidence and therapeutic outcome of pouchitis for ulcerative colitis in Japanese patients.
Topics: Adenomatous Polyposis Coli; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female | 2004 |
Clinical management of pouchitis.
Topics: Adult; Anti-Infective Agents; Biopsy; Ciprofloxacin; Colitis, Ulcerative; Diagnosis, Differential; H | 2004 |
Clinical management of pouchitis.
Topics: Adult; Anti-Infective Agents; Biopsy; Ciprofloxacin; Colitis, Ulcerative; Diagnosis, Differential; H | 2004 |
Clinical management of pouchitis.
Topics: Adult; Anti-Infective Agents; Biopsy; Ciprofloxacin; Colitis, Ulcerative; Diagnosis, Differential; H | 2004 |
Clinical management of pouchitis.
Topics: Adult; Anti-Infective Agents; Biopsy; Ciprofloxacin; Colitis, Ulcerative; Diagnosis, Differential; H | 2004 |
Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Clostridioides diffic | 2005 |
[Pouchitis, on the basis of a single observation].
Topics: Adolescent; Anti-Infective Agents; Bulgaria; Colitis, Ulcerative; Follow-Up Studies; Humans; Male; M | 2004 |
Association between fecal hydrogen sulfide production and pouchitis.
Topics: Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Feces; Female; Humans; Hydrogen Sulfide; | 2005 |
Reversible visual deficit and Corpus callosum lesions due to metronidazole toxicity.
Topics: Adult; Anti-Infective Agents; Colitis, Ulcerative; Corpus Callosum; Diagnosis, Differential; Evoked | 2005 |
"Diversion" colitis caused by Clostridium difficile infection: report of a case.
Topics: Administration, Rectal; Adult; Anti-Infective Agents; Clostridioides difficile; Clostridium Infectio | 2006 |
Inflammatory Bowel Disease and Clostridium difficile-associated diarrhea: a growing problem.
Topics: Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colitis, Ulcerat | 2007 |
Acute pancreatitis as a possible consequence of metronidazole during a relapse of ulcerative colitis.
Topics: Acute Disease; Adult; Colitis, Ulcerative; Gastrointestinal Agents; Humans; Male; Metronidazole; Pan | 2007 |
Medical therapy of inflammatory bowel disease.
Topics: Acute Disease; Adjuvants, Immunologic; Anus Diseases; Azathioprine; Colitis, Ulcerative; Crohn Disea | 1980 |
[Crohn disease and ulcerative colitis - current status: internal medicine aspects].
Topics: Adrenal Cortex Hormones; Azathioprine; Colitis, Ulcerative; Crohn Disease; Diagnosis, Differential; | 1981 |
Current status of medical treatment for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Mercaptopurine; M | 1983 |
Acute ulcerative colitis--a rare complication of sulfasalazine therapy.
Topics: Acute Disease; Adult; Colitis, Ulcerative; Female; Humans; Metronidazole; Sulfasalazine | 1984 |
[Therapy of chronic inflammatory bowel diseases].
Topics: Acute Disease; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Mercaptopurine; Methylpredn | 1983 |
[Clinical studies on the isolation of Clastridium difficile--13 cases].
Topics: Adult; Aged; Clostridium; Colitis, Ulcerative; Enterocolitis, Pseudomembranous; Feces; Female; Human | 1983 |
Pouch ileitis: report of a case with severe systemic manifestations.
Topics: Adult; Colitis, Ulcerative; Endoscopy; Humans; Ileitis; Ileostomy; Intestinal Mucosa; Male; Metronid | 1983 |
[Ulcerative colitis and Crohn disease. Conservative therapy].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Humans; Metro | 1982 |
[Isolation of Clostridium difficile toxin from the feces of a patient with ulcerative colitis (author's transl)].
Topics: Adult; Bacterial Toxins; Clostridium Infections; Colitis, Ulcerative; Feces; Female; Humans; Metroni | 1981 |
Anal canal inflammation after ileal pouch-anal anastomosis. The need for treatment.
Topics: Administration, Rectal; Adolescent; Adult; Aged; Anal Canal; Biopsy; Ciprofloxacin; Colitis, Ulcerat | 1995 |
Blastocystis hominis in inflammatory bowel disease.
Topics: Adult; Animals; Blastocystis hominis; Blastocystis Infections; Child; Colitis, Ulcerative; Crohn Dis | 1993 |
Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy.
Topics: Adenomatous Polyposis Coli; Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Colitis, | 1996 |
Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy.
Topics: Adenomatous Polyposis Coli; Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Colitis, | 1996 |
Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy.
Topics: Adenomatous Polyposis Coli; Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Colitis, | 1996 |
Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy.
Topics: Adenomatous Polyposis Coli; Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Colitis, | 1996 |
Crohn's disease and ulcerative colitis with onset in the same year in two sisters.
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Child; Colitis, Ulcerative; Colonoscopy; Crohn Di | 1996 |
Immune thrombocytopenia and ulcerative colitis: response to nonoperative therapy.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Ther | 1996 |
Functional results after restorative proctocolectomy complicated by pouchitis.
Topics: Adolescent; Adult; Aged; Anal Canal; Anastomosis, Surgical; Case-Control Studies; Chronic Disease; C | 1997 |
Arthritis related to ileal pouchitis following total proctocolectomy for ulcerative colitis.
Topics: Adult; Anti-Bacterial Agents; Arthritis, Reactive; Colitis, Ulcerative; Female; Humans; Male; Metron | 2001 |
Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Child; Colitis, Ulcerative; Female; Humans; Incidenc | 2001 |
Inflammatory bowel diseases 1977.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cromolyn Sodium; Diet; Eye Diseases; Humans; Joint | 1977 |
Chronic inflammatory bowel disease.
Topics: Adolescent; Adult; Azathioprine; Bile Acids and Salts; Child; Cholestyramine Resin; Colitis, Ulcerat | 1977 |
Drugs used in treatment of large bowel disease.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antidiarrheals; Azathioprine; Cathartics; Colitis, U | 1979 |
[Cutaneous amebiases (stimulating pyoderma gangrenosum in ulcerative colitis)].
Topics: Amebiasis; Colitis, Ulcerative; Colostomy; Entamoeba histolytica; Entamoebiasis; Humans; Male; Metro | 1976 |
Protective effect of metronidazole in experimental ulcerative colitis.
Topics: Animals; Carrageenan; Cecum; Colitis, Ulcerative; Enterobacter; Escherichia coli; Gentamicins; Guine | 1978 |
[Long-term therapy in ulcerative colitis and Crohn's disease].
Topics: Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Metronidazole; Patie | 1979 |
Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Animals; Bacteria; Colitis, Ulcerative; Colon; Colonic Neo | 1992 |
Substitution of factor XIII: a therapeutic approach to ulcerative colitis.
Topics: Adrenal Cortex Hormones; Adult; Blood Coagulation Disorders; Colitis, Ulcerative; Factor XIII; Facto | 1991 |
Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease.
Topics: Adult; Azathioprine; Blood Cell Count; Colitis, Ulcerative; Crohn Disease; Female; Humans; Inflammat | 1991 |
Blastocystis hominis complicating ulcerative colitis.
Topics: Adult; Animals; Blastocystis; Colitis, Ulcerative; Feces; Humans; Male; Metronidazole; Protozoan Inf | 1991 |
[Crohn disease and ulcerative colitis].
Topics: Adrenal Cortex Hormones; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Cyclosporins | 1990 |
Pouchitis and gastric hyposecretion: cause or effect?
Topics: Adenomatous Polyposis Coli; Adult; Anal Canal; Anastomosis, Surgical; Cimetidine; Colitis, Ulcerativ | 1990 |
[Protective effect of metronidazole in experimental ulcerative colitis induced by dextran sulfate sodium].
Topics: Animals; Bacteroidaceae; Colitis, Ulcerative; Cricetinae; Dextran Sulfate; Dextrans; Feces; Intestin | 1987 |
Cyclosporin A treatment in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Adult; Colitis, Ulcerative; Crohn Disease; Cyclosporins; Drug Therapy, Comb | 1989 |
Pregnancy, fertility, and inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Fe | 1985 |
Therapeutical experiments in ulcerative colitis and Crohn's disease.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Follow-Up Studies; Huma | 1985 |
Disposition of metronidazole and its effects on sulphasalazine metabolism in patients with inflammatory bowel disease.
Topics: Administration, Oral; Biological Availability; Colitis, Ulcerative; Crohn Disease; Drug Evaluation; | 1986 |
[Inflammatory bowel disease; internal therapy].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Drug Combinations | 1988 |
Severe steroid responsive pneumonitis associated with pyoderma gangrenosum and ulcerative colitis.
Topics: Ampicillin; Colitis, Ulcerative; Erythromycin; Female; Gentamicins; Humans; Metronidazole; Middle Ag | 1985 |
Studies of human amebiasis. I. Clinical and laboratory findings in eight cases of acute amebic colitis.
Topics: Adolescent; Adult; Barium Sulfate; Biopsy; Colitis; Colitis, Ulcerative; Colon; Colon, Sigmoid; Colo | 1973 |
Intestinal amebiasis. A roentgen analysis of 19 cases including 2 case reports.
Topics: Abscess; Aged; Cecal Diseases; Colitis, Ulcerative; Colonic Diseases; Colonic Neoplasms; Diagnosis, | 1974 |
[Treatment of acute amebic rectocolitis].
Topics: Acute Disease; Adult; Arsenicals; Child, Preschool; Colitis, Ulcerative; Dysentery, Amebic; Emetine; | 1970 |